Herbert J. Kramer
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Renin-angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.
Journal: Clinical and experimental hypertension (New York, N.Y. : 1993)
Published: March 14, 2017
Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Journal: Journal of hypertension
Published: July 19, 2016
Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Journal: Clinical and experimental pharmacology & physiology
Published: September 30, 2015
Identification of Putative Natriuretic Hormones Isolated from Human Urine.
Journal: Frontiers in endocrinology
Published: January 16, 2015
A tribute to Hugh de Wardener.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: November 26, 2014
Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
Journal: Physiological research
Published: September 07, 2014
Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats.
Journal: Vascular pharmacology
Published: August 30, 2014
Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats.
Journal: Clinical and experimental pharmacology & physiology
Published: July 24, 2014
Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats.
Journal: Life sciences
Published: October 02, 2013
Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.
Journal: Clinical and experimental pharmacology & physiology
Published: August 10, 2013
Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME.
Journal: Journal of hypertension
Published: January 12, 2013
Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system.
Journal: Clinical and experimental pharmacology & physiology
Published: June 04, 2012
Last Updated: 09/26/2026